Valeo Pharma Inc VPHIF

Healthcare

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.

GREY:VPHIF - Post by User

Valeo Pharma Inc > Hesperco get the green light with Health Canada

<< Previous

Bullboard Posts

Next >>

Comment by kooter33on Sep 10, 2020 10:45am

178 Views

Post# 31532928

RE:RE:RE:Hesperco get the green light with Health Canada

eric40 wrote: You are right, this is a natural product. It cannot be patent protected. However, it is just a matter of good marketing and taking advantage of the covid situation with a brand name for a product that help boost the immune system. So why not. Hesperco won't bring sales of 100 millions (well we never know with the covid situation!) but it will probably bring a nice add up revenu and and is low cost high margin.

The approval of Redeska is what I am waiting for. It should come anytime now and this will bring huge revenu.

Hope you are right about Redeska, because the market is not being kind to VPH right now. What is with that. Oiljack was indicating that this stock is very cheap. CEO was indicating that the company would be on the QX soon, and that there were bigs things coming. i waiting to see if they do get cashflow positive by year end. Oct 2020.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario